Cancer Communications
indexed by SCI
BMC


NEWS AND VIEWS
Unveiling quality of clinical trial in China: from concern to confirmation
Huiyao Huang, Yiru Hou, Hong Fang, Ling Xu, Yue Yu, Huifang Zhang, Jing Zhang, Yu Tang, Gongtao Lan, Wenbao Zhang, Ning Li
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/6/2024   doi:10.1002/cac2.12528
RESEARCH HIGHLIGHTS
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture
Chu-Xia Deng
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/6/2024   doi:10.1002/cac2.12529
ORIGINAL ARTICLE
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
Jing Zheng, Tao Wang, Yunpeng Yang, Jie Huang, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong, Yanqiu Zhao, Yiping Zhang, Yong Song, Yi Hu, Zhuang Yu, Youling Gong, Yuan Chen, Feng Ye, Shucai Zhang, Lejie Cao, Yun Fan, Gang Wu, Yubiao Guo, Chengzhi Zhou, Kewei Ma, Jian Fang, Weineng Feng, Yunpeng Liu, Zhendong Zheng, Gaofeng Li, Huijie Wang, Shundong Cang, Ning Wu, Wei Song, Xiaoqing Liu, Shijun Zhao, Lieming Ding, Giovanni Selvaggi, Yang Wang, Shanshan Xiao, Qian Wang, Zhilin Shen, Jianya Zhou, Jianying Zhou, Li Zhang
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/29/2024   doi:10.1002/cac2.12524
ORIGINAL ARTICLE
Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies
Lu Tang, Huan Zhang, Fen Zhou, Qiuzhe Wei, Mengyi Du, Jianghua Wu, Chenggong Li, Wenjing Luo, Jie Zhou, Xindi Wang, Zhaozhao Chen, Yinqiang Zhang, Zhongpei Huang, Zhuolin Wu, Yuxi Wen, Huiwen Jiang, Danying Liao, Haiming Kou, Wei Xiong, Heng Mei, Yu Hu
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/26/2024   doi:10.1002/cac2.12525
ORIGINAL ARTICLE
SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation
Shiyu Zhang, Xing Jia, Haojiang Dai, Xingxin Zhu, Wenfeng Song, Suchen Bian, Hao Wu, Shinuo Chen, Yangbo Tang, Junran Chen, Cheng Jin, Mengqiao Zhou, Haiyang Xie, Shusen Zheng, Penghong Song
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/26/2024   doi:10.1002/cac2.12527
ORIGINAL ARTICLE
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/26/2024   doi:10.1002/cac2.12523
LETTER TO THE JOURNAL
A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy
Yingqiang Liu, Linjiang Tong, Mengge Zhang, Qi Zhang, Qiupei Liu, Fang Feng, Yan Li, Mengzhen Lai, Haotian Tang, Yi Chen, Meiyu Geng, Wenhu Duan, Jian Ding, Hua Xie
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/9/2024   doi:10.1002/cac2.12521
REVIEW
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/4/2024   doi:10.1002/cac2.12520
LETTER TO THE EDITOR
AP4 induces JNK1 and a miR-22-3p/FOSL1 feed-forward loop to activate AP-1 and promote colorectal cancer metastasis
Jinjiang Chou, Markus Kaller, Matjaz Rokavec, Fangteng Liu, Heiko Hermeking
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 1/15/2024   doi:10.1002/cac2.12514
REVIEW
Cellular metabolism: a key player in cancer ferroptosis
Xianjie Jiang, Qiu Peng, Mingjing Peng, Linda Oyang, Honghan Wang, Qiang Liu, Xuemeng Xu, Nayiyuan Wu, Shiming Tan, Wenjuan Yang, Yaqian Han, Jinguan Lin, Longzheng Xia, Yanyan Tang, Xia Luo, Jie Dai, Yujuan Zhou, Qianjin Liao
Cancer Communications 2024 44:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 1/13/2024   doi:10.1002/cac2.12519

<<    Page 16 of 81  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China